Huw Smith quits Nycomed Amersham

Alan Huw Smith, corporate communications director at FTSE 100 healthcare company Nycomed Amersham, has announced he is to leave his post in March.

Alan Huw Smith, corporate communications director at FTSE 100

healthcare company Nycomed Amersham, has announced he is to leave his

post in March.



He will be replaced by Matthew Butler, director of corporate information

at Thames Water.



Huw Smith held joint responsibilitiy for corporate affairs with Eric

Cameron, who left the company at the end of December to start his own

agency. Huw Smith joined from Buckinghamshire-based Amersham when it

merged with Norwegian Nycomed in July last year.



’Both Eric and I made it clear that we would leave once the merger was

complete and bedded down, in order to assist the transition,’ said

Smith.



Huw Smith, who joined Amersham from a directorship of Granfield in 1994,

remains silent about his future. His remit at Nycomed includes corporate

and public affairs, and assisting with investor relations and financial

PR.



Following the departure of finance director Andrew Allner in December,

the company is looking at how to divide responsibility for investor

relations.



Allner has been replaced by former company secretary Giles Kerr.

Brunswick handle Nycomed Amersham’s financial PR.



Butler joined Thames Water in July 1996 and was responsible for bringing

together its corporate communications activities, including IR, media

relations, employee communications, branding and advertising. At Nycomed

he will oversee a ten-strong communications team.



Prior to Thames Water, Butler was the assistant private secretary to the

Prince of Wales, and remains an ’extra equerry’ to Prince Charles.



Nycomed Amersham was placed in the FTSE 100 in December, filling the

vacancy created by drinks and leisure company Grand Metropolitan’s

merger with Guinness.



The pounds 2 billion plus merger between Amersham International and

Nycomed created the largest diagnostic imaging and life sciences company

in the world. The company produces agents used to illuminate organs in

x-rays and brain scans, and a nuclear imaging product which enables

doctors to pinpoint cell disorders. Its key markets are in Europe, the

US and Japan.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.